Global High Throughput Screening Market, By Product and Services (Reagents and Assay Kits, Instruments, Consumables and Accessories, Software, Services), Technology (Cell-Based Assays, Lab-On-A-Chip, Ultra-High-Throughput Screening, Bioinformatics, Label-Free Technology), Application (Target Identification and Validation, Primary and Secondary Screening, Toxicology Assessment, Other), End Users (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
The high throughput screening market is expected to witness market growth at a rate of 7.85% in the forecast period of 2021 to 2028, and is estimated to reach the value of USD 53.66 billion by 2028. Data Bridge Market Research report on high throughput screening market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the healthcare sector globally is escalating the growth of high throughput screening market.
High-throughput screening (HTS) refers to a drug discovery process that enables automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are widely deployed in the pharmaceutical industry, leveraging robotics and automation for quickly testing biological or biochemical activity of a large number of molecules.
The surge in research and development spending across the globe acts as one of the major factors driving the growth of high throughput screening market. The adoption of open innovation models in pharmaceutical and biotechnology companies, and development of new drugs for various life-threating diseases accelerate the market growth. The rise in use of high-throughput screening for drug development, as it reduces the time taken to develop a drug, and increase in funding from government for adoption of new technologies including CRISPR-Cas9 and RNAi, and artificial intelligence, among others further influence the market. Additionally, surge in healthcare expenditure, high disposable income, end of use industries and growth in awareness positively affect the high throughput screening market. Furthermore, faster data processing and rise in automation in the field of high throughput screening extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, the capital-intensive nature of HTS instruments and complexities in assay development are expected to obstruct the market growth. The dearth of skilled operators is projected to challenge the high throughput screening market in the forecast period of 2021-2028.
This high throughput screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on high throughput screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global High Throughput Screening Market Scope and Market Size
The high throughput screening market is segmented on the basis of product and services, technology, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and services, the high throughput screening market is segmented into reagents and assay kits, instruments, consumables and accessories, software, and services. Consumables are further segmented into reagents and assay kits and laboratory equipment. Instruments are further segmented into liquid handling systems, detection systems and other instruments.
- On the basis of technology, the high throughput screening market is segmented into cell-based assays, lab-on-a-chip, ultra-high-throughput screening, bioinformatics and label-free technology. The cell based assays is further divided into 2D cell culture, 3D cell culture, and perfusion cell culture. The 3D cell culture is further divided into scaffold-based technology, scaffold-free technology. The scaffold-based technology is sub- segmented into hydrogels, inert matrix/solid scaffolds, and micropatterned surfaces. Hydrogel segment is divided into animal- derived hydrogels, synthetic hydrogels, and alginate/agarose. Animal derived hydrogels is segmented into matrigel and collagen. The scaffold-free technology is segmented into microplates, hanging drop plates, ultra-low binding plates, and other scaffold- free technologies.
- On the basis of application, the high throughput screening market is segmented into target identification and validation, primary and secondary screening, toxicology assessment and other.
- On the basis of end user, the high throughput screening market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations and others.
High Throughput Screening Market Country Level Analysis
The high throughput screening market is analyzed and market size insights and trends are provided by country, product and services, technology, application and end users as referenced above.
The countries covered in the high throughput screening market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the high throughput screening market because of the technological advancements in the US. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the rise in efforts for new pharmaceutical molecules and the adoption of newer technologies in the region.
The country section of the biaxially-oriented polyethylene terephthalate (BOPET) packaging films market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The high throughput screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for high throughput screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the high throughput screening market. The data is available for historic period 2010-2019.
Competitive Landscape and High Throughput Screening Market Share Analysis
The high throughput screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to high throughput screening market.
The major players covered in the high throughput screening market report are Thermo Fisher Scientific Inc., Agilent Technologies, Inc, Danaher, PerkinElmer Inc., Tecan Trading AG, Axxam SpA, Merck KGaA, Hamilton Company, Corning Incorporated, BioTek Instruments, Inc., Aurora Biomed Inc., General Electric, Beckman Coulter, Inc., Luminex Corporation., Charles River, AstraZeneca, and Sygnature Discovery, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.